Long pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #50,221 to #50,270.
- (hist) Palifermin (patient information) [3,910 bytes]
- (hist) Isometheptene Mucate, Dichloralphenazone, and Acetaminophen [3,910 bytes]
- (hist) Benzoyl Peroxide (patient information) [3,910 bytes]
- (hist) Tet methylcytosine dioxygenase 3 [3,909 bytes]
- (hist) APMAP [3,909 bytes]
- (hist) NINJ1 [3,909 bytes]
- (hist) RWDD3 [3,909 bytes]
- (hist) Hunter syndrome overview [3,909 bytes]
- (hist) Impetigo laboratory findings [3,909 bytes]
- (hist) Thrombosis (patient information) [3,909 bytes]
- (hist) Babesiosis risk factors [3,909 bytes]
- (hist) Botulism physical examination [3,909 bytes]
- (hist) Rubella pathophysiology [3,909 bytes]
- (hist) Sinus arrhythmia [3,909 bytes]
- (hist) Cervical cerclage [3,909 bytes]
- (hist) MT-TD [3,908 bytes]
- (hist) FAM127A [3,908 bytes]
- (hist) TAF3 [3,908 bytes]
- (hist) TIPARP [3,908 bytes]
- (hist) Mupirocin warnings and precautions [3,908 bytes]
- (hist) Chronic obstructive pulmonary disease classification [3,908 bytes]
- (hist) Cardiac tamponade (patient information) [3,908 bytes]
- (hist) Burkholderia [3,908 bytes]
- (hist) Epistaxis Other Imaging Findings [3,907 bytes]
- (hist) Renal agenesis pathophysiology [3,907 bytes]
- (hist) Tetradecanoylphorbol-13-acetate response element gene transcriptions [3,907 bytes]
- (hist) Nucleoporin 43 [3,907 bytes]
- (hist) ESF1 [3,907 bytes]
- (hist) Aminosalicylic acid clinical pharmacology [3,907 bytes]
- (hist) Chikungunya natural history, complications and prognosis [3,907 bytes]
- (hist) Spinal Muscular atrophy therapeutics development in SMA [3,907 bytes]
- (hist) Lie detection [3,907 bytes]
- (hist) List of Schedule II drugs [3,907 bytes]
- (hist) RAB40A [3,907 bytes]
- (hist) Synthetic element [3,907 bytes]
- (hist) Xanthan lyase [3,907 bytes]
- (hist) Telephone counseling [3,907 bytes]
- (hist) ATC code D07 [3,907 bytes]
- (hist) BCR gene [3,907 bytes]
- (hist) Phenylthiocarbamide [3,907 bytes]
- (hist) Chenodeoxycholic acid [3,907 bytes]
- (hist) EAF2 [3,906 bytes]
- (hist) TOMM40L [3,906 bytes]
- (hist) Hepatitis D prevention [3,906 bytes]
- (hist) The Living Guidelines: Patients at High Risk for Developing Heart Failure. Polling Results for CLASS IIa Guidelines [3,906 bytes]
- (hist) ABT-089 [3,906 bytes]
- (hist) The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy Polling Results for CLASS IIb Guidelines [3,906 bytes]
- (hist) Buchnera (proteobacteria) [3,906 bytes]
- (hist) Costal cartilages [3,906 bytes]
- (hist) Interstitial cell of Cajal [3,906 bytes]